5 research outputs found
Π‘ΡΠ°Π²Π½ΠΈΡΠ΅Π»ΡΠ½Π°Ρ ΠΎΡΠ΅Π½ΠΊΠ° ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ Π²ΠΈΠ±ΡΠ°ΡΠΈΠΎΠ½Π½ΡΡ ΡΠΈΠ·ΠΈΠΎΡΠ΅ΡΠ°ΠΏΠ΅Π²ΡΠΈΡΠ΅ΡΠΊΠΈΡ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠ² Π² ΡΠ°Π½Π½ΠΈΠ΅ ΡΡΠΎΠΊΠΈ ΠΏΠΎΡΠ»Π΅ ΠΊΠ°ΡΠ΄ΠΈΠΎΡ ΠΈΡΡΡΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ Π²ΠΌΠ΅ΡΠ°ΡΠ΅Π»ΡΡΡΠ²
Postoperative respiratory complications in patients undergoing cardiac surgery occur in 20β30% cases, and the most of them can be associated with ineffective cough and bronchial mucus evacuation.The objective. Comparative assessment of effectiveness and safety of methods for stimulating the evacuation of bronchial secretions using oscillatory PEP-therapy (Acapella Duet), oscillatory chest compression insufflator-aspirator βComfort Cough Plusβ, and the traditional method of manual chest percussion in the early period after cardiac surgery.Subjects and Methods. The prospective study included 120 cardiac surgery patients. They were divided into 3 groups (40 in each), depending on the type of the applied respiratory procedure. Distribution into groups was carried out by random selection. All procedures were performed 10β12 hours after tracheal extubation. Before the procedure and 20 minutes after it, the efficiency of sputum discharge was assessed, gas exchange indices on room air breathing and maximum inspiratory lung capacity (MILC) were measured.Results. Ineffective bronchial mucus evacuating in the early period after tracheal extubation was observed in 86.7% of the patients. A single procedure of both PEP-therapy (Group 1) and mechanical cough stimulation (Group 2) led to improved sputum passage, as evidenced by an increase in the number of patients with productive cough by 4.25 times (p < 0.0009) and 5.3 times (p < 0.0007), respectively. In patients of Groups 1 and 2, an increase in MILC was observed (by 42.2% and 60.0%, respectively, p = 0.000001), the difference between the groups was statistically significant. In Control Group 3, with manual physiotherapy, the average increase in MILC was only 11.6%. Mechanical respiratory therapy procedures led to significant improvement in gas exchange variables, as evidenced by an increase in SpO2 in Groups 1 and 2 (p = 0.000009 and 0.000001, respectively) and a decrease in the proportion of patients with impaired oxygenating lung function (SpO2 below 92%) by 11 and 12 times, respectively (p < 0.01). The most significant changes were revealed in case of mechanical stimulation with aspirator-insufflator due to combination of two methods (oscillatory chest compression and lung inflation). In Control Group, no significant changes of gas exchange variables were observed.Conclusion: Mechanical vibratory methods for stimulating the bronchial secretion evacuation have significant advantages over classical manual chest massage in patients after cardiac surgery. Their positive effect on sputum passage, ventilatory parameters and gas exchange was noted, and the most pronounced effect was observed after oscillatory chest compression with insufflator-aspirator. The procedures were well tolerated and there were no complications associated with them.ΠΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΡ ΡΠΎ ΡΡΠΎΡΠΎΠ½Ρ ΡΠΈΡΡΠ΅ΠΌΡ Π΄ΡΡ
Π°Π½ΠΈΡ Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² ΠΏΠΎΡΠ»Π΅ ΠΊΠ°ΡΠ΄ΠΈΠΎΡ
ΠΈΡΡΡΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
Π²ΠΌΠ΅ΡΠ°ΡΠ΅Π»ΡΡΡΠ² Π²ΡΡΡΠ΅ΡΠ°ΡΡΡΡ Π² 20β30% ΡΠ»ΡΡΠ°Π΅Π²; ΠΌΠ½ΠΎΠ³ΠΈΠ΅ ΠΈΠ· Π½ΠΈΡ
ΡΠ²ΡΠ·Π°Π½Ρ Ρ Π½Π΅ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΠΉ ΡΠ²Π°ΠΊΡΠ°ΡΠΈΠ΅ΠΉ Π±ΡΠΎΠ½Ρ
ΠΈΠ°Π»ΡΠ½ΠΎΠ³ΠΎ ΡΠ΅ΠΊΡΠ΅ΡΠ° Π² ΡΠ°Π½Π½ΠΈΠ΅ ΡΡΠΎΠΊΠΈ ΠΏΠΎΡΠ»Π΅ ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΈ. Π¦Π΅Π»Ρ: ΡΡΠ°Π²Π½ΠΈΡΡ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ ΠΈ Π±Π΅Π·ΠΎΠΏΠ°ΡΠ½ΠΎΡΡΡ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠ² ΡΡΠΈΠΌΡΠ»ΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΡΠ²Π°ΠΊΡΠ°ΡΠΈΠΈ Π±ΡΠΎΠ½Ρ
ΠΈΠ°Π»ΡΠ½ΠΎΠ³ΠΎ ΡΠ΅ΠΊΡΠ΅ΡΠ° Ρ ΠΏΠΎΠΌΠΎΡΡΡ ΠΎΡΡΠΈΠ»Π»ΡΡΠΎΡΠ½ΠΎΠΉ Π ΠΠ -ΡΠ΅ΡΠ°ΠΏΠΈΠΈ, Π°ΠΏΠΏΠ°ΡΠ°ΡΠ½ΠΎΠΉ ΡΡΠΈΠΌΡΠ»ΡΡΠΈΠΈ ΠΊΠ°ΡΠ»Ρ ΠΌΠ΅Ρ
Π°Π½ΠΈΡΠ΅ΡΠΊΠΈΠΌ ΠΈΠ½ΡΡΡΡΠ»ΡΡΠΎΡΠΎΠΌ-Π°ΡΠΏΠΈΡΠ°ΡΠΎΡΠΎΠΌ ΠΈ ΡΡΠ°Π΄ΠΈΡΠΈΠΎΠ½Π½ΠΎΠ³ΠΎ ΠΌΠ΅ΡΠΎΠ΄Π° ΠΌΠ°Π½ΡΠ°Π»ΡΠ½ΠΎΠΉ ΠΏΠ΅ΡΠΊΡΡΡΠΈΠΈ Π³ΡΡΠ΄Π½ΠΎΠΉ ΠΊΠ»Π΅ΡΠΊΠΈ Π² ΡΠ°Π½Π½Π΅ΠΌ ΠΏΠΎΡΠ»Π΅ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΎΠ½Π½ΠΎΠΌ ΠΏΠ΅ΡΠΈΠΎΠ΄Π΅ Ρ ΠΊΠ°ΡΠ΄ΠΈΠΎΡ
ΠΈΡΡΡΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ².ΠΠ°ΡΠ΅ΡΠΈΠ°Π» ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. ΠΡΠΎΡΠΏΠ΅ΠΊΡΠΈΠ²Π½ΠΎΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ Π²ΠΊΠ»ΡΡΠ°Π»ΠΎ 120 ΠΊΠ°ΡΠ΄ΠΈΠΎΡ
ΠΈΡΡΡΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ². ΠΡΠ΄Π΅Π»Π΅Π½Ρ 3 Π³ΡΡΠΏΠΏΡ ΠΏΠΎ 40 Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΊΠ°ΠΆΠ΄Π°Ρ Π² Π·Π°Π²ΠΈΡΠΈΠΌΠΎΡΡΠΈ ΠΎΡ Π²ΠΈΠ΄Π° ΠΏΡΠΈΠΌΠ΅Π½ΡΠ΅ΠΌΠΎΠ³ΠΎ ΡΠ΅ΡΠΏΠΈΡΠ°ΡΠΎΡΠ½ΠΎΠ³ΠΎ Π²ΠΎΠ·Π΄Π΅ΠΉΡΡΠ²ΠΈΡ ΠΏΠΎΡΠ»Π΅ ΠΊΠ°ΡΠ΄ΠΈΠΎΡ
ΠΈΡΡΡΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΉ. Π Π°ΡΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ ΠΏΠΎ Π³ΡΡΠΏΠΏΠ°ΠΌ ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΠ»ΠΈ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΡΠ»ΡΡΠ°ΠΉΠ½ΠΎΠ³ΠΎ ΠΎΡΠ±ΠΎΡΠ°. ΠΡΠ΅ ΠΏΡΠΎΡΠ΅Π΄ΡΡΡ Π²ΡΠΏΠΎΠ»Π½ΡΠ»ΠΈ ΡΠ΅ΡΠ΅Π· 10β12 Ρ ΠΏΠΎΡΠ»Π΅ ΡΠΊΡΡΡΠ±Π°ΡΠΈΠΈ ΡΡΠ°Ρ
Π΅ΠΈ (ΡΠΏΡΡΡΡ 15β20 Ρ ΠΏΠΎΡΠ»Π΅ ΠΎΠΊΠΎΠ½ΡΠ°Π½ΠΈΡ ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΈ) ΠΏΡΠΈ Π΄ΡΡ
Π°Π½ΠΈΠΈ Π²ΠΎΠ·Π΄ΡΡ
ΠΎΠΌ. ΠΠΎ ΠΏΡΠΎΡΠ΅Π΄ΡΡΡ ΠΈ ΡΠ΅ΡΠ΅Π· 20 ΠΌΠΈΠ½ ΠΏΠΎΡΠ»Π΅ Π½Π΅Π΅ ΠΎΡΠ΅Π½ΠΈΠ²Π°Π»ΠΈ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ ΠΎΡΡ
ΠΎΠΆΠ΄Π΅Π½ΠΈΡ ΠΌΠΎΠΊΡΠΎΡΡ, ΠΈΠ·ΠΌΠ΅ΡΡΠ»ΠΈ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΠΈ Π³Π°Π·ΠΎΠΎΠ±ΠΌΠ΅Π½Π° ΠΈ ΠΌΠ°ΠΊΡΠΈΠΌΠ°Π»ΡΠ½ΡΡ ΠΈΠ½ΡΠΏΠΈΡΠ°ΡΠΎΡΠ½ΡΡ Π΅ΠΌΠΊΠΎΡΡΡ Π»Π΅Π³ΠΊΠΈΡ
(ΠΠΠΠ).Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. ΠΠ°ΡΡΡΠ΄Π½Π΅Π½ΠΈΡ Π² ΡΠ²Π°ΠΊΡΠ°ΡΠΈΠΈ ΠΌΠΎΠΊΡΠΎΡΡ ΠΏΡΠΈ ΠΊΠ°ΡΠ»Π΅ Π² ΡΠ°Π½Π½ΠΈΠ΅ ΡΡΠΎΠΊΠΈ ΠΏΠΎΡΠ»Π΅ ΡΠΊΡΡΡΠ±Π°ΡΠΈΠΈ ΡΡΠ°Ρ
Π΅ΠΈ Π½Π°Π±Π»ΡΠ΄Π°Π»ΠΈΡΡ Ρ 86,7% Π±ΠΎΠ»ΡΠ½ΡΡ
. ΠΡΠΎΠ²Π΅- Π΄Π΅Π½ΠΈΠ΅ ΠΎΠ΄Π½ΠΎΠΊΡΠ°ΡΠ½ΠΎΠ³ΠΎ ΡΠ΅Π°Π½ΡΠ° ΠΊΠ°ΠΊ Π ΠΠ -ΡΠ΅ΡΠ°ΠΏΠΈΠΈ Ρ ΠΏΠΎΠΌΠΎΡΡΡ ΡΠΏΠΈΡΠΎΡΡΠ΅Π½Π°ΠΆΠ΅ΡΠ° Acapella Duet (1-Ρ Π³ΡΡΠΏΠΏΠ°), ΡΠ°ΠΊ ΠΈ Π°ΠΏΠΏΠ°ΡΠ°ΡΠ½ΠΎΠΉ ΡΡΠΈΠΌΡΠ»ΡΡΠΈΠΈ ΠΊΠ°ΡΠ»Ρ Ρ ΠΏΠΎΠΌΠΎΡΡΡ ΠΎΡΡΠΈΠ»Π»ΡΡΠΎΡΠ½ΠΎΠΉ ΠΊΠΎΠΌΠΏΡΠ΅ΡΡΠΈΠΈ Π³ΡΡΠ΄Π½ΠΎΠΉ ΠΊΠ»Π΅ΡΠΊΠΈ Π°ΠΏΠΏΠ°ΡΠ°ΡΠΎΠΌ Comfort Cough Plus (2-Ρ Π³ΡΡΠΏΠΏΠ°) ΠΏΡΠΈΠ²ΠΎΠ΄ΠΈΠ»ΠΎ ΠΊ ΡΠ»ΡΡΡΠ΅Π½ΠΈΡ ΠΏΠ°ΡΡΠ°ΠΆΠ° ΠΌΠΎΠΊΡΠΎΡΡ, ΠΎ ΡΠ΅ΠΌ ΡΠ²ΠΈΠ΄Π΅ΡΠ΅Π»ΡΡΡΠ²ΠΎΠ²Π°Π»ΠΎ ΡΠ²Π΅Π»ΠΈΡΠ΅Π½ΠΈΠ΅ ΡΠΈΡΠ»Π° Π±ΠΎΠ»ΡΠ½ΡΡ
Ρ ΠΏΡΠΎΠ΄ΡΠΊΡΠΈΠ²Π½ΡΠΌ ΠΎΡΡ
ΠΎΠΆΠ΄Π΅Π½ΠΈΠ΅ΠΌ ΠΌΠΎΠΊΡΠΎΡΡ Π² 4,25 ΡΠ°Π·Π° (p < 0,0009) ΠΈ Π² 5,3 ΡΠ°Π·Π° (p < 0,0007) ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²Π΅Π½Π½ΠΎ. Π£ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² 1-ΠΉ ΠΈ 2-ΠΉ Π³ΡΡΠΏΠΏ Π½Π°Π±Π»ΡΠ΄Π°Π»ΠΎΡΡ ΡΠ²Π΅Π»ΠΈΡΠ΅Π½ΠΈΠ΅ ΠΠΠΠ (Π½Π° 42,2 ΠΈ 60,0% ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²Π΅Π½Π½ΠΎ, p = 0,000001), ΡΠ°Π·Π»ΠΈΡΠΈΡ ΠΌΠ΅ΠΆΠ΄Ρ Π³ΡΡΠΏΠΏΠ°ΠΌΠΈ Π·Π½Π°ΡΠΈΠΌΡ. Π ΠΊΠΎΠ½ΡΡΠΎΠ»ΡΠ½ΠΎΠΉ, 3-ΠΉ Π³ΡΡΠΏΠΏΠ΅, ΠΏΡΠΈ ΠΌΠ°Π½ΡΠ°Π»ΡΠ½ΠΎΠΉ ΡΠΈΠ·ΠΈΠΎΡΠ΅ΡΠ°ΠΏΠΈΠΈ ΡΡΠ΅Π΄Π½ΠΈΠΉ ΠΏΡΠΈΡΠΎΡΡ ΠΠΠΠ ΡΠΎΡΡΠ°Π²ΠΈΠ» Π»ΠΈΡΡ 11,6%. ΠΡΠΎΡΠ΅Π΄ΡΡΡ Π°ΠΏΠΏΠ°ΡΠ°ΡΠ½ΠΎΠΉ ΡΠ΅ΡΠΏΠΈΡΠ°ΡΠΎΡΠ½ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ ΠΏΡΠΈΠ²ΠΎΠ΄ΠΈΠ»ΠΈ ΠΊ Π·Π½Π°ΡΠΈΠΌΠΎΠΌΡ ΡΠ»ΡΡΡΠ΅Π½ΠΈΡ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Π΅ΠΉ Π³Π°Π·ΠΎΠΎΠ±ΠΌΠ΅Π½Π°: ΡΠ²Π΅Π»ΠΈΡΠ΅Π½ΠΈΡ SpO2 Π² 1-ΠΉ ΠΈ 2-ΠΉ Π³ΡΡΠΏΠΏΠ°Ρ
(p = 0,000009 ΠΈ 0,000001 cΠΎΠΎΡΠ²Π΅ΡΡΡΠ²Π΅Π½Π½ΠΎ) ΠΈ ΡΠΌΠ΅Π½ΡΡΠ΅Π½ΠΈΡ Π΄ΠΎΠ»ΠΈ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ Π½Π°ΡΡΡΠ΅Π½ΠΈΠ΅ΠΌ ΠΎΠΊΡΠΈΠ³Π΅Π½ΠΈΡΡΡΡΠ΅ΠΉ ΡΡΠ½ΠΊΡΠΈΠΈ Π»Π΅Π³ΠΊΠΈΡ
(SpO2 < 92%) Π² 11 ΠΈ 12 ΡΠ°Π· ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²Π΅Π½Π½ΠΎ (p < 0,01). ΠΠ°ΠΈΠ±ΠΎΠ»Π΅Π΅ Π·Π½Π°ΡΠΈΠΌΡΠ΅ ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΡ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Π΅ΠΉ Π³Π°Π·ΠΎΠΎΠ±ΠΌΠ΅Π½Π° Π²ΡΡΠ²Π»Π΅Π½Ρ ΠΏΡΠΈ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠΈ Π°ΠΏΠΏΠ°ΡΠ°ΡΠ½ΠΎΠΉ ΡΡΠΈΠΌΡΠ»ΡΡΠΈΠΈ ΠΊΠ°ΡΠ»Ρ ΠΈΠ½ΡΡΡΡΠ»ΡΡΠΎΡΠΎΠΌ-Π°ΡΠΏΠΈΡΠ°ΡΠΎΡΠΎΠΌ Π±Π»Π°Π³ΠΎΠ΄Π°ΡΡ ΡΠΎΡΠ΅ΡΠ°Π½ΠΈΡ ΠΎΡΡΠΈΠ»Π»ΡΡΠΎΡΠ½ΠΎΠΉ ΠΊΠΎΠΌΠΏΡΠ΅ΡΡΠΈΠΈ Π³ΡΡΠ΄Π½ΠΎΠΉ ΠΊΠ»Π΅ΡΠΊΠΈ Ρ ΡΠ°Π·Π΄ΡΠ²Π°- Π½ΠΈΠ΅ΠΌ Π»Π΅Π³ΠΊΠΈΡ
. Π Π³ΡΡΠΏΠΏΠ΅ ΠΊΠΎΠ½ΡΡΠΎΠ»Ρ Π·Π½Π°ΡΠΈΠΌΠΎΠΉ Π΄ΠΈΠ½Π°ΠΌΠΈΠΊΠΈ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Π΅ΠΉ Π³Π°Π·ΠΎΠΎΠ±ΠΌΠ΅Π½Π° Π½Π΅ Π½Π°Π±Π»ΡΠ΄Π°Π»ΠΎΡΡ.ΠΡΠ²ΠΎΠ΄. ΠΠΈΠ±ΡΠ°ΡΠΈΠΎΠ½Π½ΡΠ΅ ΠΌΠ΅ΡΠΎΠ΄Ρ ΡΡΠΈΠΌΡΠ»ΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΡΠ²Π°ΠΊΡΠ°ΡΠΈΠΈ Π±ΡΠΎΠ½Ρ
ΠΈΠ°Π»ΡΠ½ΠΎΠ³ΠΎ ΡΠ΅ΠΊΡΠ΅ΡΠ° ΠΈΠΌΠ΅ΡΡ Π·Π½Π°ΡΠΈΡΠ΅Π»ΡΠ½ΡΠ΅ ΠΏΡΠ΅ΠΈΠΌΡΡΠ΅ΡΡΠ²Π° ΠΏΠΎ ΡΡΠ°Π²Π½Π΅Π½ΠΈΡ Ρ ΠΊΠ»Π°ΡΡΠΈΡΠ΅ΡΠΊΠΈΠΌ ΠΌΠ°Π½ΡΠ°Π»ΡΠ½ΡΠΌ ΠΌΠ°ΡΡΠ°ΠΆΠ΅ΠΌ Π³ΡΡΠ΄Π½ΠΎΠΉ ΠΊΠ»Π΅ΡΠΊΠΈ Ρ ΠΊΠ°ΡΠ΄ΠΈΠΎΡ
ΠΈΡΡΡΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
Π±ΠΎΠ»ΡΠ½ΡΡ
Π² ΡΠ°Π½Π½ΠΈΠ΅ ΡΡΠΎΠΊΠΈ ΠΏΠΎΡΠ»Π΅ ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΈ. ΠΡΠΌΠ΅ΡΠ΅Π½ΠΎ ΠΈΡ
ΠΏΠΎΠ»ΠΎΠΆΠΈΡΠ΅Π»ΡΠ½ΠΎΠ΅ Π²Π»ΠΈΡΠ½ΠΈΠ΅ Π½Π° ΠΏΠ°ΡΡΠ°ΠΆ ΠΌΠΎΠΊΡΠΎΡΡ, Π²Π΅Π½ΡΠΈΠ»ΡΡΠΈΠΎΠ½Π½ΡΠ΅ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΠΈ ΠΈ ΠΎΠΊΡΠΈΠ³Π΅Π½ΠΈΡΡΡΡΡΡ ΡΡΠ½ΠΊΡΠΈΡ Π»Π΅Π³ΠΊΠΈΡ
. ΠΠ°ΠΈΠ±ΠΎΠ»Π΅Π΅ Π²ΡΡΠ°ΠΆΠ΅Π½Π½ΡΠΉ ΡΡΡΠ΅ΠΊΡ Π½Π°Π±Π»ΡΠ΄Π°Π΅ΡΡΡ ΠΏΡΠΈ Π°ΠΏΠΏΠ°ΡΠ°ΡΠ½ΠΎΠΉ ΡΡΠΈΠΌΡΠ»ΡΡΠΈΠΈ ΠΊΠ°ΡΠ»Ρ ΠΌΠ΅Ρ
Π°Π½ΠΈΡΠ΅ΡΠΊΠΈΠΌ ΠΈΠ½ΡΡΡΡΠ»ΡΡΠΎΡΠΎΠΌ-Π°ΡΠΏΠΈΡΠ°ΡΠΎΡΠΎΠΌ. ΠΡΠΌΠ΅ΡΠ΅Π½Ρ Ρ
ΠΎΡΠΎΡΠ°Ρ ΠΏΠ΅ΡΠ΅Π½ΠΎΡΠΈΠΌΠΎΡΡΡ ΠΏΡΠΎΡΠ΅Π΄ΡΡ ΠΈ ΠΎΡΡΡΡΡΡΠ²ΠΈΠ΅ ΡΠ²ΡΠ·Π°Π½Π½ΡΡ
Ρ Π½ΠΈΠΌΠΈ ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΠΉ
ΠΠΠΠ§ΠΠΠΠ ΠΠΠ‘Π’ΠΠΠΠ ΠΠ ΠΠΠΠΠΠΠΠ― Π’Π ΠΠΠΠΠ‘ΠΠΠΠΠΠ ΠΠΠ‘ΠΠΠ’Π« ΠΠ Π ΠΠΠ ΠΠΠΠ₯ΠΠ Π£Π ΠΠΠ§ΠΠ‘ΠΠΠ₯ ΠΠΠΠ ΠΠ¦ΠΠ―Π₯ Π‘ ΠΠ‘ΠΠ£Π‘Π‘Π’ΠΠΠΠΠ«Π ΠΠ ΠΠΠΠΠΠ ΠΠ©ΠΠΠΠΠ
Peri-operative bleeding in surgeries with cardiopulmonary bypass results in the increase of post-operative complications and mortality. Fibrinolysis hyperactivation is the common cause of non-operative bleeding. Materials and methods. 60 patients who had cardiac surgery with cardiopulmonary bypass were enrolled into the study. The antifibrinolytic agent (tranexamic acid) was administered to all patients: 32 patients (TA1) received an intravenous loading dose of tranexamic acid basing on 15 mg/kg during 20 min. with the consequent infusion of 1 mg/(kg Γ h-1) + 500 mg during cardiopulmonary bypass; 28 patients (TA2) received intravenous loading dose of tranexamic acid (15 mg/kg for 20 minutes) with the consequent infusion of 1 mg/(kg Γ h-1) + 500 mg during cardiopulmonary bypassΒ + 1000 mg administered into the pericardial cavity and sternum before its closure. The peri-operative blood loss and volume of blood transfusion (erythrocyte suspension, fresh frozen plasma, platelet concentrate) were assessed. Results. Intra-operative blood loss made 815 (800β862) ml in TA1 group and 700 (650β735) ml in TA2 group. The volume of the post-operative blood loss in TA2 group was confidently lower compared to TA1 group: 170 (100β240) ml versus 275 (180β307) ml respectively. The frequency of erythrocyte suspension transfusion in the post-operative period did not differ significantly and the frequency of fresh frozen plasma transfusion was 2.5 lower in TA2 group compared to TA1 group. Conclusions. Blood-saving effect of the system administration of tranexamic acid is enhanced by local its administration into the pericardial cavity and sternum.Β ΠΠ΅ΡΠΈΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΎΠ½Π½ΠΎΠ΅ ΠΊΡΠΎΠ²ΠΎΡΠ΅ΡΠ΅Π½ΠΈΠ΅ ΠΏΡΠΈ ΠΎΠΏΠ΅ΡΠ°ΡΠΈΡΡ
Ρ ΠΈΡΠΊΡΡΡΡΠ²Π΅Π½Π½ΡΠΌ ΠΊΡΠΎΠ²ΠΎΠΎΠ±ΡΠ°ΡΠ΅Π½ΠΈΠ΅ΠΌ (ΠΠ) ΠΏΡΠΈΠ²ΠΎΠ΄ΠΈΡ ΠΊ ΡΠ²Π΅Π»ΠΈΡΠ΅Π½ΠΈΡ ΡΡΠΎΠ²Π½Ρ ΠΏΠΎΡΠ»Π΅ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΎΠ½Π½ΡΡ
ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΠΉ ΠΈ ΡΠΌΠ΅ΡΡΠ½ΠΎΡΡΠΈ. ΠΡΠΈΡΠΈΠ½Π°ΠΌΠΈ Π½Π΅Ρ
ΠΈΡΡΡΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΊΡΠΎΠ²ΠΎΡΠ΅ΡΠ΅Π½ΠΈΡ Π½Π΅ΡΠ΅Π΄ΠΊΠΎ ΡΠ²Π»ΡΠ΅ΡΡΡ Π³ΠΈΠΏΠ΅ΡΠ°ΠΊΡΠΈΠ²ΠΈΠ·Π°ΡΠΈΡ ΡΠΈΠ±ΡΠΈΠ½ΠΎΠ»ΠΈΠ·Π°. ΠΠ°ΡΠ΅ΡΠΈΠ°Π»Ρ ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. Π ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ Π²ΠΊΠ»ΡΡΠ΅Π½ΠΎ 60 Π±ΠΎΠ»ΡΠ½ΡΡ
, ΠΎΠΏΠ΅ΡΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
Π½Π° ΡΠ΅ΡΠ΄ΡΠ΅ Ρ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ΠΌ ΠΠ. ΠΡΠ΅ΠΌ Π±ΠΎΠ»ΡΠ½ΡΠΌ Π±ΡΠ» Π²Π²Π΅Π΄Π΅Π½ Π°Π½ΡΠΈΡΠΈΠ±ΡΠΈΠ½ΠΎΠ»ΠΈΡΠΈΠΊ (ΡΡΠ°Π½Π΅ΠΊΡΠ°ΠΌΠΎΠ²Π°Ρ ΠΊΠΈΡΠ»ΠΎΡΠ°): Π² 32 ΡΠ»ΡΡΠ°ΡΡ
(Π’Π1) Π²Π²Π΅Π΄Π΅Π½Π° Π²Π½ΡΡΡΠΈΠ²Π΅Π½Π½Π°Ρ Π½Π°Π³ΡΡΠ·ΠΎΡΠ½Π°Ρ Π΄ΠΎΠ·Π° Π’Π ΠΈΠ· ΡΠ°ΡΡΠ΅ΡΠ° 15 ΠΌΠ³/ΠΊΠ³ Π² ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ 20 ΠΌΠΈΠ½ Ρ ΠΏΠΎΡΠ»Π΅Π΄ΡΡΡΠ΅ΠΉ ΠΈΠ½ΡΡΠ·ΠΈΠ΅ΠΉ 1 ΠΌΠ³/(ΠΊΠ³ β Ρ-1) + 500 ΠΌΠ³ Π² ΠΠΠ; Ρ 28 Π±ΠΎΠ»ΡΠ½ΡΡ
(Π’Π2) ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½Π° Π²Π½ΡΡΡΠΈΠ²Π΅Π½Π½Π°Ρ Π½Π°Π³ΡΡΠ·ΠΎΡΠ½Π°Ρ Π΄ΠΎΠ·Π° Π’Π (15Β ΠΌΠ³/ΠΊΠ³ Π·Π° 20 ΠΌΠΈΠ½) Ρ ΠΏΠΎΡΠ»Π΅Π΄ΡΡΡΠ΅ΠΉ ΠΈΠ½ΡΡΠ·ΠΈΠ΅ΠΉ 1 ΠΌΠ³/(ΠΊΠ³ β Ρ-1) + 500 ΠΌΠ³ Π² ΠΠΠ + 1 000 ΠΌΠ³ Π² ΠΏΠΎΠ»ΠΎΡΡΡ ΠΏΠ΅ΡΠΈΠΊΠ°ΡΠ΄Π° ΠΈ Π·Π° Π³ΡΡΠ΄ΠΈΠ½Ρ ΠΏΠ΅ΡΠ΅Π΄ Π΅Π΅ ΡΠ²Π΅Π΄Π΅Π½ΠΈΠ΅ΠΌ. ΠΡΠ΅Π½ΠΈΠ²Π°Π»ΠΈ ΠΏΠ΅ΡΠΈΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΎΠ½Π½ΡΡ ΠΊΡΠΎΠ²ΠΎΠΏΠΎΡΠ΅ΡΡ ΠΈ ΠΎΠ±ΡΠ΅ΠΌ Π³Π΅ΠΌΠΎΡΡΠ°Π½ΡΡΡΠ·ΠΈΠΈ (ΡΡΠΈΡΡΠΎΡΠΈΡΠ°ΡΠ½Π°Ρ Π²Π·Π²Π΅ΡΡ, ΡΠ²Π΅ΠΆΠ΅Π·Π°ΠΌΠΎΡΠΎΠΆΠ΅Π½Π½Π°Ρ ΠΏΠ»Π°Π·ΠΌΠ°, ΡΡΠΎΠΌΠ±ΠΎΡΠΈΡΠ°ΡΠ½Π°Ρ ΠΌΠ°ΡΡΠ°). Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. ΠΠ½ΡΡΠ°ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΎΠ½Π½Π°Ρ ΠΊΡΠΎΠ²ΠΎΠΏΠΎΡΠ΅ΡΡ ΡΠΎΡΡΠ°Π²ΠΈΠ»Π° Π² Π³ΡΡΠΏΠΏΠ΅ Π’Π1 815 (800β862) ΠΌΠ», Π² Π’Π2 β 700 (650β735) ΠΌΠ». ΠΠ±ΡΠ΅ΠΌ ΠΏΠΎΡΠ»Π΅ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΎΠ½Π½ΠΎΠΉ ΠΊΡΠΎΠ²ΠΎΠΏΠΎΡΠ΅ΡΠΈ Π² Π³ΡΡΠΏΠΏΠ΅ Π’Π2 Π±ΡΠ» Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½ΠΎ Π½ΠΈΠΆΠ΅, ΡΠ΅ΠΌ Π² Π³ΡΡΠΏΠΏΠ΅ Π’Π1: ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²Π΅Π½Π½ΠΎ 170 (100β240) ΠΌΠ» ΠΏΡΠΎΡΠΈΠ² 275 (180β307) ΠΌΠ». Π§Π°ΡΡΠΎΡΠ° ΠΏΠ΅ΡΠ΅Π»ΠΈΠ²Π°Π½ΠΈΡ ΡΡΠΈΡΡΠΎΡΠΈΡΠ°ΡΠ½ΠΎΠΉ Π²Π·Π²Π΅ΡΠΈ Π² ΠΏΠΎΡΠ»Π΅ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΎΠ½Π½ΠΎΠΌ ΠΏΠ΅ΡΠΈΠΎΠ΄Π΅ ΡΡΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΎ Π½Π΅ ΡΠ°Π·Π»ΠΈΡΠ°Π»Π°ΡΡ, ΡΠ°ΡΡΠΎΡΠ° ΠΏΠ΅ΡΠ΅Π»ΠΈΠ²Π°Π½ΠΈΡ ΡΠ²Π΅ΠΆΠ΅Π·Π°ΠΌΠΎΡΠΎΠΆΠ΅Π½Π½ΠΎΠΉ ΠΏΠ»Π°Π·ΠΌΡ Π² Π’Π2 Π±ΡΠ»Π° Π² 2,5 ΡΠ°Π·Π° Π½ΠΈΠΆΠ΅, ΡΠ΅ΠΌ Π² Π’Π1. ΠΡΠ²ΠΎΠ΄Ρ. ΠΡΠΎΠ²ΠΎΡΠ±Π΅ΡΠ΅Π³Π°ΡΡΠΈΠΉ ΡΡΡΠ΅ΠΊΡ ΡΠΈΡΡΠ΅ΠΌΠ½ΠΎΠ³ΠΎ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ ΡΡΠ°Π½Π΅ΠΊΡΠ°ΠΌΠΎΠ²ΠΎΠΉ ΠΊΠΈΡΠ»ΠΎΡΡ ΡΡΠΈΠ»ΠΈΠ²Π°Π΅ΡΡΡ ΠΌΠ΅ΡΡΠ½ΡΠΌ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠ° ΠΏΡΠΈ Π²Π²Π΅Π΄Π΅Π½ΠΈΠΈ Π΅Π³ΠΎ Π² ΠΏΠΎΠ»ΠΎΡΡΡ ΠΏΠ΅ΡΠΈΠΊΠ°ΡΠ΄Π° ΠΈ Π·Π° Π³ΡΡΠ΄ΠΈΠ½Ρ.
Π‘ΡΠ°Π²Π½ΠΈΡΠ΅Π»ΡΠ½Π°Ρ ΠΎΡΠ΅Π½ΠΊΠ° ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠΎΠ² ΠΈΠ·ΠΌΠ΅ΡΠ΅Π½ΠΈΡ Π΅ΠΌΠΊΠΎΡΡΠΈ Π²Π΄ΠΎΡ Π° Ρ ΠΏΠΎΠΌΠΎΡΡΡ ΠΏΠΎΠ±ΡΠ΄ΠΈΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ ΡΠΏΠΈΡΠΎΠΌΠ΅ΡΡΠ° ΠΈ ΠΌΠ΅ΡΠΎΠ΄Π° ΡΠ»ΡΡΡΠ°Π·Π²ΡΠΊΠΎΠ²ΠΎΠΉ ΡΠΏΠΈΡΠΎΠ³ΡΠ°ΡΠΈΠΈ Π² ΡΠ°Π½Π½Π΅ΠΌ ΠΏΠΎΡΠ»Π΅ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΎΠ½Π½ΠΎΠΌ ΠΏΠ΅ΡΠΈΠΎΠ΄Π΅ Ρ ΠΊΠ°ΡΠ΄ΠΈΠΎΡ ΠΈΡΡΡΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ²
Incentive spirometry is one of the most common methods used for respiratory rehabilitation in the early period after cardiac surgery. Inspiratory capacity values, obtained by a patient using spirometer, are not reliably trusted.Objectives. To compare volumetric parameters measured with incentive spirometer and results obtained with bedside ultrasound-based spirometer to assure the feasibility of the use of incentive spirometry to assess the inspiratory capacity and eο¬ectiveness of postoperative respiratory rehabilitation.Materials and methods. The study included 50 patients after elective cardiac surgery. Pulmonary rehabilitation involved the use of various respiratory therapy methods. Spirography was performed before and after each session. Both approaches were used simultaneously to obtain the spirometry maximum inspiratory capacity (SMIC) with a bedside ultrasonic spirography and maximum inspiratory capacity (MIC) index using an incentive spirometer. Patientβs discomfort and adverse events during the procedures were recorded.Results. The absolute values of the MIC measured before and after each session by the two methods were dissimilar, however, the average increment values (6) did not show statistically significant differences. The correlation analysis revealed a strong positive statistically significant relationship between 6 SMIC and 6 MIC (R = 0.74 before the session, R = 0.79 after the session, R = 0.77 across the whole data set, P < 0.01), also consistent with the BlandβAltman analysis, evidencing that more than 95% of all values fell within Β± 1.96 SD of the mean difference. The inspiratory spirometry method showed good diagnostic accuracy (sensitivity 87%, specificity 85%, area under the curve (AUC) 0.8 (95% CI: [0.76; 0.83]), P < 0.001). Refusals of procedure were more often documented with ultrasonic spirography.Conclusion. The increment in the inspiratory capacity index measured with incentive spirometer shows good agreement with ultrasonic spirography measurements. Therefore, incentive spirometry can be reliably used to assess the effectiveness of respiratory rehabilitation interventions in cardiac surgery patients during early postoperative period.ΠΠΎΠ±ΡΠ΄ΠΈΡΠ΅Π»ΡΠ½Π°Ρ ΡΠΏΠΈΡΠΎΠΌΠ΅ΡΡΠΈΡ ΠΎΡΠ½ΠΎΡΠΈΡΡΡ ΠΊ Π½Π°ΠΈΠ±ΠΎΠ»Π΅Π΅ ΡΠ°ΡΠΏΡΠΎΡΡΡΠ°Π½Π΅Π½Π½ΡΠΌ ΠΌΠ΅ΡΠΎΠ΄Π°ΠΌ, ΠΏΡΠΈΠΌΠ΅Π½ΡΠ΅ΠΌΡΠΌ Π΄Π»Ρ ΡΠ΅ΡΠΏΠΈΡΠ°ΡΠΎΡΠ½ΠΎΠΉ ΡΠ΅Π°Π±ΠΈΠ»ΠΈΡΠ°ΡΠΈΠΈ Π² ΡΠ°Π½Π½ΠΈΠ΅ ΡΡΠΎΠΊΠΈ ΠΏΠΎΡΠ»Π΅ ΠΊΠ°ΡΠ΄ΠΈΠΎΡ
ΠΈΡΡΡΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
Π²ΠΌΠ΅ΡΠ°ΡΠ΅Π»ΡΡΡΠ². ΠΡΠΎΡΠ΅Π΄ΡΡΠ° ΠΎΡΠ½ΠΎΠ²Π°Π½Π° Π½Π° ΡΠ°ΠΌΠΎΡΡΠΎΡΡΠ΅Π»ΡΠ½ΠΎΠΌ ΠΈΠ·ΠΌΠ΅ΡΠ΅Π½ΠΈΠΈ ΠΎΠ±ΡΠ΅ΠΌΠ° Π²Π΄ΠΎΡ
Π° ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠΌ, ΠΎΠ΄Π½Π°ΠΊΠΎ ΠΎΡΡΠ°Π΅ΡΡΡ Π½Π΅ΡΡΠ½ΡΠΌ, Π½Π°ΡΠΊΠΎΠ»ΡΠΊΠΎ ΠΌΠΎΠΆΠ½ΠΎ Π΄ΠΎΠ²Π΅ΡΡΡΡ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠ°ΠΌ ΡΡΠΈΡ
ΠΈΠ·ΠΌΠ΅ΡΠ΅Π½ΠΈΠΉ. Β Π¦Π΅Π»Ρ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ. Π‘ΡΠ°Π²Π½ΠΈΡΡ Π²ΠΎΠ»ΡΠΌΠ΅ΡΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΠΈ, ΠΈΠ·ΠΌΠ΅ΡΠ΅Π½Π½ΡΠ΅ Ρ ΠΏΠΎΠΌΠΎΡΡΡ ΠΏΠΎΠ±ΡΠ΄ΠΈΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ ΡΠΏΠΈΡΠΎΠΌΠ΅ΡΡΠ° Ρ Π΄Π°Π½Π½ΡΠΌΠΈ ΠΏΡΠΈΠΊΡΠΎΠ²Π°ΡΠ½ΠΎΠΉ ΡΠ»ΡΡΡΠ°Π·Π²ΡΠΊΠΎΠ²ΠΎΠΉ ΡΠΏΠΈΡΠΎΠΌΠ΅ΡΡΠΈΠΈ ΠΈ ΠΎΡΠ΅Π½ΠΈΡΡ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΡ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΡ ΠΏΠΎΠ±ΡΠ΄ΠΈΡΠ΅Π»ΡΠ½ΠΎΠΉ ΡΠΏΠΈΡΠΎΠΌΠ΅ΡΡΠΈΠΈ Π΄Π»Ρ ΠΎΡΠ΅Π½ΠΊΠΈ Π΅ΠΌΠΊΠΎΡΡΠΈ Β Β Π²Π΄ΠΎΡ
Π° ΠΈ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ ΠΏΠΎΡΠ»Π΅ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΎΠ½Π½ΠΎΠΉ ΡΠ΅ΡΠΏΠΈΡΠ°ΡΠΎΡΠ½ΠΎΠΉ ΡΠ΅Π°Π±ΠΈΠ»ΠΈΡΠ°ΡΠΈΠΈ.ΠΠ°ΡΠ΅ΡΠΈΠ°Π»Ρ ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ.Β Π ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ Π²ΠΎΡΠ»ΠΈ 50 ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² ΠΏΠΎΡΠ»Π΅ ΠΏΠ»Π°Π½ΠΎΠ²ΡΡ
ΠΊΠ°ΡΠ΄ΠΈΠΎΡ
ΠΈΡΡΡΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΉ. Π Π΅Π°Π±ΠΈΠ»ΠΈΡΠ°ΡΠΈΡ ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΠ»ΠΈ Ρ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ ΡΠ°Π·Π»ΠΈΡΠ½ΡΡ
ΡΠ΅ΡΠΏΠΈΡΠ°ΡΠΎΡΠ½ΡΡ
ΠΌΠ΅ΡΠΎΠ΄ΠΎΠ². ΠΠΎ ΠΈ ΠΏΠΎΡΠ»Π΅ ΠΊΠ°ΠΆΠ΄ΠΎΠ³ΠΎ ΡΠ΅Π°Π½ΡΠ° Π²ΡΠΏΠΎΠ»Π½ΡΠ»ΠΈ ΡΠΏΠΈΡΠΎΠ³ΡΠ°ΡΠΈΡ Ρ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ ΠΏΡΠΈΠΊΡΠΎΠ²Π°ΡΠ½ΠΎΠ³ΠΎ ΡΠ»ΡΡΡΠ°Π·Π²ΡΠΊΠΎΠ²ΠΎΠ³ΠΎ ΡΠΏΠΈΡΠΎΠΌΠ΅ΡΡΠ°. ΠΡΠ΅Π½ΠΈΠ²Π°Π»ΠΈ ΠΌΠ°ΠΊΡΠΈΠΌΠ°Π»ΡΠ½ΡΡ Π΅ΠΌΠΊΠΎΡΡΡ Π²Π΄ΠΎΡ
Π° (Π‘ΠΠΠΠ΄), ΠΎΠ΄Π½ΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΠΎ ΠΎΠΏΡΠ΅Π΄Π΅Π»ΡΠ»ΠΈ Β ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Ρ ΠΌΠ°ΠΊΡΠΈΠΌΠ°Π»ΡΠ½ΠΎΠΉ Π΅ΠΌΠΊΠΎΡΡΠΈ Π²Π΄ΠΎΡ
Π° (ΠΠΠΠ΄) Ρ ΠΏΠΎΠΌΠΎΡΡΡ ΠΏΠΎΠ±ΡΠ΄ΠΈΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ ΡΠΏΠΈΡΠΎΠΌΠ΅ΡΡΠ°. Π Π΅Π³ΠΈΡΡΡΠΈΡΠΎΠ²Π°Π»ΠΈΒ Π½Π΅ΠΆΠ΅Π»Π°ΡΠ΅Π»ΡΠ½ΡΠ΅ ΡΠ²Π»Π΅Π½ΠΈΡ ΠΈ Π΄ΠΈΡΠΊΠΎΠΌΡΠΎΡΡ ΠΏΡΠΈ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠΈ ΠΏΡΠΎΡΠ΅Π΄ΡΡ.Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. ΠΠ±ΡΠΎΠ»ΡΡΠ½ΡΠ΅ Π²Π΅Π»ΠΈΡΠΈΠ½Ρ ΠΌΠ°ΠΊΡΠΈΠΌΠ°Π»ΡΠ½ΠΎΠΉ Π΅ΠΌΠΊΠΎΡΡΠΈ Π²Π΄ΠΎΡ
Π°, ΠΈΠ·ΠΌΠ΅ΡΠ΅Π½Π½ΡΠ΅ Π΄ΠΎ ΠΈ ΠΏΠΎΡΠ»Π΅ ΠΊΠ°ΠΆΠ΄ΠΎΠ³ΠΎ ΡΠ΅Π°Π½ΡΠ° Ρ ΠΏΠΎΠΌΠΎΡΡΡ ΡΡΠ°Π²Π½ΠΈΠ²Π°Π΅ΠΌΡΡ
ΠΌΠ΅ΡΠΎΠ΄ΠΎΠ², ΠΎΡΠ»ΠΈΡΠ°ΡΡΡΡ, ΠΎΠ΄Π½Π°ΠΊΠΎ ΡΡΠ΅Π΄Π½ΠΈΠ΅ Π·Π½Π°ΡΠ΅Π½ΠΈΡ ΠΈΡ
ΠΏΡΠΈΡΠΎΡΡΠ° (Ξ) Π½Π΅ ΠΈΠΌΠ΅Π»ΠΈ ΡΡΠ°ΡΠΈΡΡΠΈΡΠ΅ΡΠΊΠΈ Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½ΡΡ
ΡΠ°Π·Π»ΠΈΡΠΈΠΉ. ΠΠΎ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠ°ΠΌ ΠΊΠΎΡΡΠ΅Π»ΡΡΠΈΠΎΠ½Π½ΠΎΠ³ΠΎ Π°Π½Π°Π»ΠΈΠ·Π° Π²ΡΡΠ²Π»Π΅Π½Π° ΡΠΈΠ»ΡΠ½Π°Ρ ΠΏΠΎΠ»ΠΎΠΆΠΈΡΠ΅Π»ΡΠ½Π°Ρ ΡΡΠ°ΡΠΈΡΡΠΈΡΠ΅ΡΠΊΠΈ Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½Π°Ρ Π²Π·Π°ΠΈΠΌΠΎΡΠ²ΡΠ·Ρ ΠΌΠ΅ΠΆΠ΄Ρ Ξ Π‘ΠΠΠΠ΄ ΠΈ Ξ ΠΠΠΠ΄ (Π΄ΠΎ ΡΠ΅Π°Π½ΡΠ° r = 0,74, ΠΏΠΎΡΠ»Π΅ ΡΠ΅Π°Π½ΡΠ° r = 0,79, ΠΏΠΎ Π²ΡΠ΅ΠΌΡ ΠΌΠ°ΡΡΠΈΠ²Ρ Π΄Π°Π½Π½ΡΡ
r = 0,77, Β Ρ<0,01), ΠΊΠΎΡΠΎΡΠ°Ρ ΠΈΠΌΠ΅Π΅Ρ Ρ
ΠΎΡΠΎΡΡΡ ΡΠΎΠ³Π»Π°ΡΠΎΠ²Π°Π½Π½ΠΎΡΡΡ ΠΏΠΎ Π°Π½Π°Π»ΠΈΠ·Ρ ΠΠ»ΡΠ½Π΄Π°βΠΠ»ΡΡΠΌΠ°Π½Π°, ΠΎ ΡΠ΅ΠΌ ΡΠ²ΠΈΠ΄Π΅ΡΠ΅Π»ΡΡΡΠ²ΡΠ΅Ρ ΡΠΎ, ΡΡΠΎ Β Π±ΠΎΠ»Π΅Π΅ 95% Π·Π½Π°ΡΠ΅Π½ΠΈΠΉΒ Π½Π°Ρ
ΠΎΠ΄ΠΈΠ»ΠΈΡΡ Π² ΠΏΡΠ΅Π΄Π΅Π»Π°Ρ
Β Β± 1,96 SD ΠΎΡ ΡΡΠ΅Π΄Π½Π΅ΠΉ ΡΠ°Π·Π½ΠΈΡΡ. ΠΠ΅ΡΠΎΠ΄ ΠΏΠΎΠ±ΡΠ΄ΠΈΡΠ΅Π»ΡΠ½ΠΎΠΉ ΡΠΏΠΈΡΠΎΠΌΠ΅ΡΡΠΈΠΈ ΠΏΠΎΠΊΠ°Π·Π°Π» Ρ
ΠΎΡΠΎΡΡΡ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΡΠ΅ΡΠΊΡΡ ΡΠΎΡΠ½ΠΎΡΡΡ ΠΏΡΠΈ ROC-Π°Π½Π°Π»ΠΈΠ·Π΅ (ΡΡΠ²ΡΡΠ²ΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΡ 87%, ΡΠΏΠ΅ΡΠΈΡΠΈΡΠ½ΠΎΡΡΡ 85%, ΠΏΠ»ΠΎΡΠ°Π΄Ρ ΠΏΠΎΠ΄ ΠΊΡΠΈΠ²ΠΎΠΉ (AUC) 0,8 (95% ΠΠ: [0,76;0,83]), Ρ<0,001). ΠΡΠΊΠ°Π· ΠΎΡ ΠΏΡΠΎΡΠ΅Π΄ΡΡΡ ΡΠ°ΡΠ΅ Π½Π°Π±Π»ΡΠ΄Π°Π»ΠΈ ΠΏΡΠΈ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠΈ ΠΌΠ΅ΡΠΎΠ΄Π° ΡΠ»ΡΡΡΠ°Π·Π²ΡΠΊΠΎΠ²ΠΎΠΉ ΡΠΏΠΈΡΠΎΠ³ΡΠ°ΡΠΈΠΈ.ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. ΠΡΠΈΡΠΎΡΡ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Ρ Π΅ΠΌΠΊΠΎΡΡΠΈ Π²Π΄ΠΎΡ
Π°, ΠΈΠ·ΠΌΠ΅ΡΠ΅Π½Π½ΠΎΠΉ Ρ ΠΏΠΎΠΌΠΎΡΡΡ ΠΏΠΎΠ±ΡΠ΄ΠΈΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ ΡΠΏΠΈΡΠΎΠΌΠ΅ΡΡΠ°, Ρ
ΠΎΡΠΎΡΠΎ ΡΠΎΠ³Π»Π°ΡΡΠ΅ΡΡΡ Ρ ΠΈΠ·ΠΌΠ΅ΡΠ΅Π½Π½ΡΠΌ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΡΠ»ΡΡΡΠ°Π·Π²ΡΠΊΠΎΠ²ΠΎΠΉΒ ΡΠΏΠΈΡΠΎΠ³ΡΠ°ΡΠΈΠΈ ΠΈ ΠΌΠΎΠΆΠ΅Ρ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°ΡΡΡΡ Π΄Π»Ρ ΠΎΡΠ΅Π½ΠΊΠΈ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ ΡΠ΅Π°Π±ΠΈΠ»ΠΈΡΠ°ΡΠΈΠΎΠ½Π½ΡΡ
ΠΌΠ΅ΡΠΎΠΏΡΠΈΡΡΠΈΠΉ Π² ΡΠ°Π½Π½Π΅ΠΌ ΠΏΠΎΡΠ»Π΅ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΎΠ½Π½ΠΎΠΌ ΠΏΠ΅ΡΠΈΠΎΠ΄Π΅ Ρ ΠΊΠ°ΡΠ΄ΠΈΠΎΡ
ΠΈΡΡΡΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ²
VALUE OF LOCAL ADMINISTRATION OF TRANEXAMIC ACID IN CARDIAC SURGERY WITHΒ CARDIOPULMONARY BYPASS
Peri-operative bleeding in surgeries with cardiopulmonary bypass results in the increase of post-operative complications and mortality. Fibrinolysis hyperactivation is the common cause of non-operative bleeding. Materials and methods. 60 patients who had cardiac surgery with cardiopulmonary bypass were enrolled into the study. The antifibrinolytic agent (tranexamic acid) was administered to all patients: 32 patients (TA1) received an intravenous loading dose of tranexamic acid basing on 15 mg/kg during 20 min. with the consequent infusion of 1 mg/(kg Γ h-1) + 500 mg during cardiopulmonary bypass; 28 patients (TA2) received intravenous loading dose of tranexamic acid (15 mg/kg for 20 minutes) with the consequent infusion of 1 mg/(kg Γ h-1) + 500 mg during cardiopulmonary bypassΒ + 1000 mg administered into the pericardial cavity and sternum before its closure. The peri-operative blood loss and volume of blood transfusion (erythrocyte suspension, fresh frozen plasma, platelet concentrate) were assessed. Results. Intra-operative blood loss made 815 (800β862) ml in TA1 group and 700 (650β735) ml in TA2 group. The volume of the post-operative blood loss in TA2 group was confidently lower compared to TA1 group: 170 (100β240) ml versus 275 (180β307) ml respectively. The frequency of erythrocyte suspension transfusion in the post-operative period did not differ significantly and the frequency of fresh frozen plasma transfusion was 2.5 lower in TA2 group compared to TA1 group. Conclusions. Blood-saving effect of the system administration of tranexamic acid is enhanced by local its administration into the pericardial cavity and sternum